MediBIC Group provides healthcare and drug development services. It provides genetic testing services with diagnostic tools to doctors; GLP-compliant gene profiling services to pharmaceutical companies; and sample banking and management services, as well as focuses on providing health care services to pets. The company is also involved in developing a cell culture system; selling consumables; promoting licensing activities for the pancreatic cancer drug Glufosfamide; the research and development of pharmaceuticals and diagnostic agents, etc.; and providing data analysis for preventive health care, as well as clinical trial services to cell therapy. MediBIC Group was founded in 2000 and is headquartered in Tokyo, Japan.
(2369:Tokyo Stock Exchange)
Rohto Tokyo Building
Phone: 81 3 5439 9691
Fax: 81 3 5439 9696www.medibic.com
|No competitor information is available for 2369.|
|View Industry Companies|
|Price/Cash Flow||NM||Not Meaningful|
Sponsored Financial Commentaries
To contact MEDIBIC GROUP, please visit www.medibic.com. Company data is provided by Capital IQ. Please use this form to report any data issues.